Callan Family Office LLC purchased a new stake in shares of Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 206,499 shares of the company's stock, valued at approximately $1,970,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Procyon Advisors LLC grew its position in Haleon by 41.3% during the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company's stock valued at $2,196,000 after buying an additional 67,329 shares during the period. HighTower Advisors LLC boosted its stake in shares of Haleon by 27.2% during the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company's stock worth $3,701,000 after acquiring an additional 74,970 shares during the last quarter. Jane Street Group LLC grew its position in shares of Haleon by 1,689.4% during the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company's stock valued at $2,803,000 after acquiring an additional 250,169 shares during the period. Chartwell Investment Partners LLC increased its stake in shares of Haleon by 107.8% in the 3rd quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company's stock worth $5,030,000 after purchasing an additional 246,594 shares in the last quarter. Finally, Townsquare Capital LLC raised its holdings in Haleon by 29.8% in the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company's stock worth $5,032,000 after purchasing an additional 109,217 shares during the period. Hedge funds and other institutional investors own 6.67% of the company's stock.
Analyst Ratings Changes
Several analysts have issued reports on HLN shares. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday, January 10th. Hsbc Global Res lowered shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. HSBC reaffirmed a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Sanford C. Bernstein cut shares of Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Six analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $10.95.
Get Our Latest Analysis on Haleon
Haleon Price Performance
NYSE HLN traded up $0.03 during trading hours on Tuesday, reaching $10.40. The company's stock had a trading volume of 12,999,785 shares, compared to its average volume of 6,565,392. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $47.06 billion, a price-to-earnings ratio of 30.57, a PEG ratio of 2.82 and a beta of 0.25. The firm's 50-day moving average price is $9.69 and its 200-day moving average price is $9.87.
Haleon (NYSE:HLN - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. On average, equities research analysts predict that Haleon plc will post 0.43 EPS for the current fiscal year.
Haleon Increases Dividend
The company also recently announced a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. This represents a dividend yield of 1.6%. This is a boost from Haleon's previous -- dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. Haleon's payout ratio is 58.97%.
Haleon Company Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Articles

Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.